HEADER LIGASE 12-MAR-22 7Z6L TITLE CRYSTAL STRUCTURE OF PROTAC 5 IN COMPLEX WITH THE BROMODOMAIN OF HUMAN TITLE 2 SMARCA2 AND PVHL:ELONGINC:ELONGINB COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROBABLE GLOBAL TRANSCRIPTION ACTIVATOR SNF2L2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ATP-DEPENDENT HELICASE SMARCA2,BRG1-ASSOCIATED FACTOR 190B, COMPND 5 BAF190B,PROTEIN BRAHMA HOMOLOG,HBRM,SNF2-ALPHA,SWI/SNF-RELATED COMPND 6 MATRIX-ASSOCIATED ACTIN-DEPENDENT REGULATOR OF CHROMATIN SUBFAMILY A COMPND 7 MEMBER 2; COMPND 8 EC: 3.6.4.-; COMPND 9 ENGINEERED: YES; COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR; COMPND 12 CHAIN: B; COMPND 13 SYNONYM: PROTEIN G7,PVHL; COMPND 14 ENGINEERED: YES; COMPND 15 MOL_ID: 3; COMPND 16 MOLECULE: ELONGIN-C; COMPND 17 CHAIN: C; COMPND 18 SYNONYM: ELOC,ELONGIN 15 KDA SUBUNIT,RNA POLYMERASE II TRANSCRIPTION COMPND 19 FACTOR SIII SUBUNIT C,SIII P15,TRANSCRIPTION ELONGATION FACTOR B COMPND 20 POLYPEPTIDE 1; COMPND 21 ENGINEERED: YES; COMPND 22 MOL_ID: 4; COMPND 23 MOLECULE: ELONGIN-B; COMPND 24 CHAIN: D; COMPND 25 SYNONYM: ELOB,ELONGIN 18 KDA SUBUNIT,RNA POLYMERASE II TRANSCRIPTION COMPND 26 FACTOR SIII SUBUNIT B,SIII P18,TRANSCRIPTION ELONGATION FACTOR B COMPND 27 POLYPEPTIDE 2; COMPND 28 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SMARCA2, BAF190B, BRM, SNF2A, SNF2L2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PDEST15; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 GENE: VHL; SOURCE 15 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 16 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PHAT4; SOURCE 19 MOL_ID: 3; SOURCE 20 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 21 ORGANISM_COMMON: HUMAN; SOURCE 22 ORGANISM_TAXID: 9606; SOURCE 23 GENE: ELOC, TCEB1; SOURCE 24 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 25 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 26 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 27 EXPRESSION_SYSTEM_PLASMID: PCDFDUET; SOURCE 28 MOL_ID: 4; SOURCE 29 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 30 ORGANISM_COMMON: HUMAN; SOURCE 31 ORGANISM_TAXID: 9606; SOURCE 32 GENE: ELOB, TCEB2; SOURCE 33 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 34 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 35 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 36 EXPRESSION_SYSTEM_PLASMID: PCDFDUET KEYWDS BROMODOMAIN, PROTAC COMPLEX, E3 LIGASE, LIGASE EXPDTA X-RAY DIFFRACTION AUTHOR M.J.ROY,G.BADER,W.FARNABY,A.CIULLI REVDAT 3 31-JAN-24 7Z6L 1 REMARK REVDAT 2 26-OCT-22 7Z6L 1 JRNL REVDAT 1 07-SEP-22 7Z6L 0 JRNL AUTH C.KOFINK,N.TRAINOR,B.MAIR,S.WOHRLE,M.WURM,N.MISCHERIKOW, JRNL AUTH 2 M.J.ROY,G.BADER,P.GREB,G.GARAVEL,E.DIERS,R.MCLENNAN, JRNL AUTH 3 C.WHITWORTH,V.VETMA,K.RUMPEL,M.SCHARNWEBER,J.E.FUCHS, JRNL AUTH 4 T.GERSTBERGER,Y.CUI,G.GREMEL,P.CHETTA,S.HOPF,N.BUDANO, JRNL AUTH 5 J.RINNENTHAL,G.GMASCHITZ,M.MAYER,M.KOEGL,A.CIULLI, JRNL AUTH 6 H.WEINSTABL,W.FARNABY JRNL TITL A SELECTIVE AND ORALLY BIOAVAILABLE VHL-RECRUITING PROTAC JRNL TITL 2 ACHIEVES SMARCA2 DEGRADATION IN VIVO. JRNL REF NAT COMMUN V. 13 5969 2022 JRNL REFN ESSN 2041-1723 JRNL PMID 36216795 JRNL DOI 10.1038/S41467-022-33430-6 REMARK 2 REMARK 2 RESOLUTION. 2.24 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.24 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.54 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 22540 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1127 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.010 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 11 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.24 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.35 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 91.57 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2756 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2590 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2619 REMARK 3 BIN R VALUE (WORKING SET) : 0.2560 REMARK 3 BIN FREE R VALUE : 0.3140 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.97 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 137 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3600 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 70 REMARK 3 SOLVENT ATOMS : 64 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 46.64 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 52.75 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 8.32790 REMARK 3 B22 (A**2) : -6.77330 REMARK 3 B33 (A**2) : -1.55460 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 9.74940 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.290 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.279 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.205 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.297 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.212 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.932 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.914 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3757 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5110 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1305 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 85 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 584 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3757 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 495 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4209 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.07 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.20 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.72 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 5 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|-2-110 } REMARK 3 ORIGIN FOR THE GROUP (A): -38.2673 14.8443 -13.4752 REMARK 3 T TENSOR REMARK 3 T11: -0.0048 T22: -0.1759 REMARK 3 T33: -0.0878 T12: 0.0515 REMARK 3 T13: 0.0859 T23: 0.0802 REMARK 3 L TENSOR REMARK 3 L11: 5.6972 L22: 1.7593 REMARK 3 L33: 3.5842 L12: -0.3172 REMARK 3 L13: 1.4063 L23: -0.9477 REMARK 3 S TENSOR REMARK 3 S11: 0.1694 S12: 0.2671 S13: 0.0940 REMARK 3 S21: -0.0206 S22: -0.0474 S23: 0.1062 REMARK 3 S31: -0.0778 S32: 0.0277 S33: -0.1220 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): -9.2487 2.2225 4.2725 REMARK 3 T TENSOR REMARK 3 T11: -0.0417 T22: -0.0351 REMARK 3 T33: -0.1703 T12: -0.0091 REMARK 3 T13: 0.0449 T23: 0.0778 REMARK 3 L TENSOR REMARK 3 L11: 5.3739 L22: 2.1950 REMARK 3 L33: 0.7907 L12: 2.0254 REMARK 3 L13: 0.6857 L23: 0.4414 REMARK 3 S TENSOR REMARK 3 S11: -0.1669 S12: 0.5861 S13: 0.1375 REMARK 3 S21: -0.2101 S22: 0.1619 S23: -0.1161 REMARK 3 S31: -0.0583 S32: -0.0944 S33: 0.0050 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: { C|* } REMARK 3 ORIGIN FOR THE GROUP (A): 11.5056 -6.6980 20.4532 REMARK 3 T TENSOR REMARK 3 T11: 0.0327 T22: -0.1311 REMARK 3 T33: -0.0519 T12: -0.0161 REMARK 3 T13: -0.0041 T23: -0.0097 REMARK 3 L TENSOR REMARK 3 L11: 3.4644 L22: 2.2200 REMARK 3 L33: 2.3647 L12: -0.9329 REMARK 3 L13: 0.5042 L23: -0.8175 REMARK 3 S TENSOR REMARK 3 S11: -0.0359 S12: 0.1004 S13: -0.0506 REMARK 3 S21: 0.0015 S22: 0.0342 S23: -0.0447 REMARK 3 S31: 0.0697 S32: 0.0932 S33: 0.0017 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: { D|* } REMARK 3 ORIGIN FOR THE GROUP (A): 7.4229 -11.9876 36.8492 REMARK 3 T TENSOR REMARK 3 T11: -0.0856 T22: -0.0676 REMARK 3 T33: -0.1466 T12: 0.0680 REMARK 3 T13: 0.0546 T23: 0.1030 REMARK 3 L TENSOR REMARK 3 L11: 2.3762 L22: 4.2366 REMARK 3 L33: 4.3592 L12: -1.3205 REMARK 3 L13: 1.0963 L23: -2.8694 REMARK 3 S TENSOR REMARK 3 S11: -0.1527 S12: -0.7047 S13: -0.3592 REMARK 3 S21: 0.2132 S22: 0.6543 S23: 0.5142 REMARK 3 S31: 0.0070 S32: -0.5267 S33: -0.5015 REMARK 3 REMARK 3 TLS GROUP : 5 REMARK 3 SELECTION: { A|201 } REMARK 3 ORIGIN FOR THE GROUP (A): -26.0553 8.8512 -3.7120 REMARK 3 T TENSOR REMARK 3 T11: -0.0486 T22: 0.0213 REMARK 3 T33: 0.0297 T12: 0.0039 REMARK 3 T13: 0.0228 T23: 0.0840 REMARK 3 L TENSOR REMARK 3 L11: 0.5766 L22: 0.0191 REMARK 3 L33: 1.1548 L12: 0.8987 REMARK 3 L13: 0.2168 L23: 0.8341 REMARK 3 S TENSOR REMARK 3 S11: 0.0720 S12: -0.2632 S13: -0.0303 REMARK 3 S21: -0.1524 S22: -0.0585 S23: -0.0210 REMARK 3 S31: -0.2696 S32: 0.0718 S33: -0.0135 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7Z6L COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-MAR-22. REMARK 100 THE DEPOSITION ID IS D_1292121669. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-FEB-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I24 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9686 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22540 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.240 REMARK 200 RESOLUTION RANGE LOW (A) : 48.540 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 6.480 REMARK 200 R MERGE (I) : 0.12300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.4100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.24 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.7 REMARK 200 DATA REDUNDANCY IN SHELL : 6.11 REMARK 200 R MERGE FOR SHELL (I) : 0.81100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.150 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5T35 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 33% (V/V) GLYCEROL ETHOXYLATE, 0.2 M REMARK 280 AMMONIUM CHLORIDE, 0.1 M HEPES, PH 7.5, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 43.40400 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5700 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23370 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -42.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A -9 REMARK 465 MET A -8 REMARK 465 ALA A -7 REMARK 465 GLU A -6 REMARK 465 LYS A -5 REMARK 465 LEU A -4 REMARK 465 SER A -3 REMARK 465 GLU A 111 REMARK 465 GLU A 112 REMARK 465 GLU A 113 REMARK 465 GLY B 52 REMARK 465 SER B 53 REMARK 465 MET B 54 REMARK 465 GLU B 55 REMARK 465 ALA B 56 REMARK 465 GLY B 57 REMARK 465 ARG B 58 REMARK 465 PRO B 59 REMARK 465 ARG B 60 REMARK 465 ARG B 210 REMARK 465 MET B 211 REMARK 465 GLY B 212 REMARK 465 ASP B 213 REMARK 465 GLY C 50 REMARK 465 GLN C 51 REMARK 465 PHE C 52 REMARK 465 ALA C 53 REMARK 465 GLU C 54 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 2 CG CD CE NZ REMARK 470 GLU A 27 CG CD OE1 OE2 REMARK 470 ARG A 35 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 40 CG CD OE1 OE2 REMARK 470 GLU A 43 CG CD OE1 OE2 REMARK 470 LYS A 110 CG CD CE NZ REMARK 470 ARG B 69 CG CD NE CZ NH1 NH2 REMARK 470 LEU B 140 CG CD1 CD2 REMARK 470 ARG B 177 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 199 CG CD OE1 OE2 REMARK 470 GLU B 204 CG CD OE1 OE2 REMARK 470 ARG B 205 CG CD NE CZ NH1 NH2 REMARK 470 HIS B 208 CG ND1 CD2 CE1 NE2 REMARK 470 GLN B 209 CG CD OE1 NE2 REMARK 470 MET C 16 CG SD CE REMARK 470 ASN C 55 CG OD1 ND2 REMARK 470 GLU C 56 CG CD OE1 OE2 REMARK 470 THR C 57 OG1 CG2 REMARK 470 GLU C 59 CG CD OE1 OE2 REMARK 470 MET D 1 CG SD CE REMARK 470 LYS D 46 CG CD CE NZ REMARK 470 ASP D 47 CG OD1 OD2 REMARK 470 ASP D 48 CG OD1 OD2 REMARK 470 GLN D 49 CG CD OE1 NE2 REMARK 470 ASP D 82 CG OD1 OD2 REMARK 470 ASP D 83 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 19 -168.77 -68.24 REMARK 500 ARG B 79 41.20 -105.70 REMARK 500 SER B 139 -129.80 -119.90 REMARK 500 GLN B 145 138.65 -34.34 REMARK 500 HIS D 10 -111.40 53.95 REMARK 500 ASP D 47 -124.01 67.02 REMARK 500 ALA D 67 75.10 -111.32 REMARK 500 ALA D 71 68.05 -152.93 REMARK 500 PRO D 97 -179.82 -69.09 REMARK 500 REMARK 500 REMARK: NULL DBREF 7Z6L A -7 113 UNP P51531 SMCA2_HUMAN 1373 1493 DBREF 7Z6L B 54 213 UNP P40337 VHL_HUMAN 54 213 DBREF 7Z6L C 17 112 UNP Q15369 ELOC_HUMAN 17 112 DBREF 7Z6L D 1 104 UNP Q15370 ELOB_HUMAN 1 104 SEQADV 7Z6L SER A -9 UNP P51531 EXPRESSION TAG SEQADV 7Z6L MET A -8 UNP P51531 EXPRESSION TAG SEQADV 7Z6L GLY B 52 UNP P40337 EXPRESSION TAG SEQADV 7Z6L SER B 53 UNP P40337 EXPRESSION TAG SEQADV 7Z6L MET C 16 UNP Q15369 INITIATING METHIONINE SEQRES 1 A 123 SER MET ALA GLU LYS LEU SER PRO ASN PRO PRO LYS LEU SEQRES 2 A 123 THR LYS GLN MET ASN ALA ILE ILE ASP THR VAL ILE ASN SEQRES 3 A 123 TYR LYS ASP SER SER GLY ARG GLN LEU SER GLU VAL PHE SEQRES 4 A 123 ILE GLN LEU PRO SER ARG LYS GLU LEU PRO GLU TYR TYR SEQRES 5 A 123 GLU LEU ILE ARG LYS PRO VAL ASP PHE LYS LYS ILE LYS SEQRES 6 A 123 GLU ARG ILE ARG ASN HIS LYS TYR ARG SER LEU GLY ASP SEQRES 7 A 123 LEU GLU LYS ASP VAL MET LEU LEU CYS HIS ASN ALA GLN SEQRES 8 A 123 THR PHE ASN LEU GLU GLY SER GLN ILE TYR GLU ASP SER SEQRES 9 A 123 ILE VAL LEU GLN SER VAL PHE LYS SER ALA ARG GLN LYS SEQRES 10 A 123 ILE ALA LYS GLU GLU GLU SEQRES 1 B 162 GLY SER MET GLU ALA GLY ARG PRO ARG PRO VAL LEU ARG SEQRES 2 B 162 SER VAL ASN SER ARG GLU PRO SER GLN VAL ILE PHE CYS SEQRES 3 B 162 ASN ARG SER PRO ARG VAL VAL LEU PRO VAL TRP LEU ASN SEQRES 4 B 162 PHE ASP GLY GLU PRO GLN PRO TYR PRO THR LEU PRO PRO SEQRES 5 B 162 GLY THR GLY ARG ARG ILE HIS SER TYR ARG GLY HIS LEU SEQRES 6 B 162 TRP LEU PHE ARG ASP ALA GLY THR HIS ASP GLY LEU LEU SEQRES 7 B 162 VAL ASN GLN THR GLU LEU PHE VAL PRO SER LEU ASN VAL SEQRES 8 B 162 ASP GLY GLN PRO ILE PHE ALA ASN ILE THR LEU PRO VAL SEQRES 9 B 162 TYR THR LEU LYS GLU ARG CYS LEU GLN VAL VAL ARG SER SEQRES 10 B 162 LEU VAL LYS PRO GLU ASN TYR ARG ARG LEU ASP ILE VAL SEQRES 11 B 162 ARG SER LEU TYR GLU ASP LEU GLU ASP HIS PRO ASN VAL SEQRES 12 B 162 GLN LYS ASP LEU GLU ARG LEU THR GLN GLU ARG ILE ALA SEQRES 13 B 162 HIS GLN ARG MET GLY ASP SEQRES 1 C 97 MET MET TYR VAL LYS LEU ILE SER SER ASP GLY HIS GLU SEQRES 2 C 97 PHE ILE VAL LYS ARG GLU HIS ALA LEU THR SER GLY THR SEQRES 3 C 97 ILE LYS ALA MET LEU SER GLY PRO GLY GLN PHE ALA GLU SEQRES 4 C 97 ASN GLU THR ASN GLU VAL ASN PHE ARG GLU ILE PRO SER SEQRES 5 C 97 HIS VAL LEU SER LYS VAL CYS MET TYR PHE THR TYR LYS SEQRES 6 C 97 VAL ARG TYR THR ASN SER SER THR GLU ILE PRO GLU PHE SEQRES 7 C 97 PRO ILE ALA PRO GLU ILE ALA LEU GLU LEU LEU MET ALA SEQRES 8 C 97 ALA ASN PHE LEU ASP CYS SEQRES 1 D 104 MET ASP VAL PHE LEU MET ILE ARG ARG HIS LYS THR THR SEQRES 2 D 104 ILE PHE THR ASP ALA LYS GLU SER SER THR VAL PHE GLU SEQRES 3 D 104 LEU LYS ARG ILE VAL GLU GLY ILE LEU LYS ARG PRO PRO SEQRES 4 D 104 ASP GLU GLN ARG LEU TYR LYS ASP ASP GLN LEU LEU ASP SEQRES 5 D 104 ASP GLY LYS THR LEU GLY GLU CYS GLY PHE THR SER GLN SEQRES 6 D 104 THR ALA ARG PRO GLN ALA PRO ALA THR VAL GLY LEU ALA SEQRES 7 D 104 PHE ARG ALA ASP ASP THR PHE GLU ALA LEU CYS ILE GLU SEQRES 8 D 104 PRO PHE SER SER PRO PRO GLU LEU PRO ASP VAL MET LYS HET IEI A 201 70 HETNAM IEI (2~{S},4~{R})-~{N}-[[2-[3-[4-(4-BROMANYL-7-CYCLOPENTYL- HETNAM 2 IEI 5-OXIDANYLIDENE-BENZIMIDAZOLO[1,2-A]QUINAZOLIN-9-YL) HETNAM 3 IEI PIPERIDIN-1-YL]PROPOXY]-4-(4-METHYL-1,3-THIAZOL-5-YL) HETNAM 4 IEI PHENYL]METHYL]-1-[(2~{S})-2-[(1-FLUORANYLCYCLOPROPYL) HETNAM 5 IEI CARBONYLAMINO]-3,3-DIMETHYL-BUTANOYL]-4-OXIDANYL- HETNAM 6 IEI PYRROLIDINE-2-CARBOXAMIDE HETSYN IEI (2S,4R)-N-(2-(3-(4-(4-BROMO-7-CYCLOPENTYL-5-OXO-5,7- HETSYN 2 IEI DIHYDROBENZO[4,5]IMIDAZO[1,2-A]QUINAZOLIN-9- YL) HETSYN 3 IEI PIPERIDIN-1-YL)PROPOXY)-4-(4-METHYLTHIAZOL-5-YL) HETSYN 4 IEI BENZYL)-1-((S)-2-(1-FLUOROCYCLOPROPANE-1- HETSYN 5 IEI CARBOXAMIDO)-3,3-DIMETHYLBUTANOYL)-4- HETSYN 6 IEI HYDROXYPYRROLIDINE-2-CARBOXAMIDE FORMUL 5 IEI C53 H62 BR F N8 O6 S FORMUL 6 HOH *64(H2 O) HELIX 1 AA1 PRO A 0 ASN A 16 1 17 HELIX 2 AA2 SER A 26 ILE A 30 5 5 HELIX 3 AA3 LEU A 38 ILE A 45 1 8 HELIX 4 AA4 ASP A 50 ASN A 60 1 11 HELIX 5 AA5 SER A 65 ASN A 84 1 20 HELIX 6 AA6 SER A 88 LYS A 110 1 23 HELIX 7 AA7 ASN B 141 GLN B 145 5 5 HELIX 8 AA8 THR B 157 VAL B 170 1 14 HELIX 9 AA9 LYS B 171 LEU B 178 5 8 HELIX 10 AB1 VAL B 181 ASP B 190 1 10 HELIX 11 AB2 ASN B 193 GLN B 209 1 17 HELIX 12 AB3 ARG C 33 LEU C 37 1 5 HELIX 13 AB4 SER C 39 LEU C 46 1 8 HELIX 14 AB5 PRO C 66 THR C 84 1 19 HELIX 15 AB6 ALA C 96 GLU C 98 5 3 HELIX 16 AB7 ILE C 99 ASP C 111 1 13 HELIX 17 AB8 THR D 23 LYS D 36 1 14 HELIX 18 AB9 PRO D 38 ASP D 40 5 3 HELIX 19 AC1 THR D 56 GLY D 61 1 6 SHEET 1 AA1 4 GLY B 106 TYR B 112 0 SHEET 2 AA1 4 PRO B 71 ASN B 78 -1 N SER B 72 O SER B 111 SHEET 3 AA1 4 ILE B 147 THR B 152 1 O ILE B 147 N ILE B 75 SHEET 4 AA1 4 LEU B 129 VAL B 130 -1 N LEU B 129 O THR B 152 SHEET 1 AA2 3 PRO B 95 PRO B 97 0 SHEET 2 AA2 3 VAL B 84 LEU B 89 -1 N TRP B 88 O GLN B 96 SHEET 3 AA2 3 LEU B 116 ASP B 121 -1 O ARG B 120 N LEU B 85 SHEET 1 AA3 8 GLU C 59 ASN C 61 0 SHEET 2 AA3 8 TYR C 18 ILE C 22 1 N LYS C 20 O VAL C 60 SHEET 3 AA3 8 GLU C 28 LYS C 32 -1 O PHE C 29 N LEU C 21 SHEET 4 AA3 8 THR D 12 LYS D 19 1 O THR D 13 N ILE C 30 SHEET 5 AA3 8 ASP D 2 ARG D 9 -1 N LEU D 5 O THR D 16 SHEET 6 AA3 8 ALA D 73 ALA D 81 1 O VAL D 75 N MET D 6 SHEET 7 AA3 8 GLN D 42 LYS D 46 -1 N TYR D 45 O GLY D 76 SHEET 8 AA3 8 GLN D 49 LEU D 50 -1 O GLN D 49 N LYS D 46 SHEET 1 AA4 7 GLU C 59 ASN C 61 0 SHEET 2 AA4 7 TYR C 18 ILE C 22 1 N LYS C 20 O VAL C 60 SHEET 3 AA4 7 GLU C 28 LYS C 32 -1 O PHE C 29 N LEU C 21 SHEET 4 AA4 7 THR D 12 LYS D 19 1 O THR D 13 N ILE C 30 SHEET 5 AA4 7 ASP D 2 ARG D 9 -1 N LEU D 5 O THR D 16 SHEET 6 AA4 7 ALA D 73 ALA D 81 1 O VAL D 75 N MET D 6 SHEET 7 AA4 7 THR D 84 PHE D 85 -1 O THR D 84 N ALA D 81 CRYST1 47.308 86.808 59.261 90.00 98.90 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021138 0.000000 0.003310 0.00000 SCALE2 0.000000 0.011520 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017080 0.00000